Patents by Inventor Damodar Ettyreddy

Damodar Ettyreddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11155832
    Abstract: The invention provides adenoviral vectors and compositions for the highly efficient transduction of T cells.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: October 26, 2021
    Assignee: GenVec, Inc.
    Inventors: Sebastien M. Maloveste, Damodar Ettyreddy, Douglas E. Brough
  • Publication number: 20210301303
    Abstract: The invention provides adenoviral vectors and compositions for the highly efficient transduction of T cells.
    Type: Application
    Filed: April 13, 2021
    Publication date: September 30, 2021
    Applicant: GenVec, Inc.
    Inventors: Sebastien M. Maloveste, Damodar Ettyreddy, Douglas E. Brough
  • Patent number: 10493144
    Abstract: The present invention encompasses FMDV vaccines or compositions. The invention encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: December 3, 2019
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Justin Widener, Leszlie Woodyard, Leonardo Siger, Douglas Brough, Damodar Ettyreddy, Jason Gall, Duncan McVey, Tom Burrage, Lauri Motes-Kreimeyer, Marc Fiorucci
  • Publication number: 20190233845
    Abstract: The invention provides adenoviral vectors and compositions for the highly efficient transduction of T cells.
    Type: Application
    Filed: September 29, 2017
    Publication date: August 1, 2019
    Applicant: GenVec, Inc.
    Inventors: Sebastien M. Maloveste, Damodar Ettyreddy, Douglas E. Brough
  • Publication number: 20190134183
    Abstract: The present invention encompasses FMDV vaccines or compositions. The invention encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Application
    Filed: January 17, 2019
    Publication date: May 9, 2019
    Inventors: Justin WIDENER, Leszlie Woodyard, Leonardo Siger, Douglas Brough, Damodar Ettyreddy, Jason Gall, Duncan McVey, Tom Burrage, Lauri Motes-Kreimeyer, Marc Fiorucci
  • Patent number: 10188721
    Abstract: The present invention encompasses FMDV vaccines or compositions. The invention encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: January 29, 2019
    Assignee: Merial, Inc.
    Inventors: Justin Widener, Leszlie Woodyard, Leonardo Siger, Douglas Brough, Damodar Ettyreddy, Jason Gall, Duncan McVey, Tom Burrage, Lauri Motes-Kreimeyer, Marc Fiorucci
  • Publication number: 20170216422
    Abstract: The present invention encompasses FMDV vaccines or compositions. The invention encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Application
    Filed: January 30, 2017
    Publication date: August 3, 2017
    Applicants: MERIAL INC., Genvec Inc., THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary of Homeland Security
    Inventors: Justin Widener, Leszlie Woodyward, Leonardo Siger, Douglas Brough, Damodar Ettyreddy, Jason Gall, Duncan McVey, Tom Burrage